Search research articles
Contact Us
Filters
Showing results (1-10 of 112) with videos related to
Page
of 12
Sort By:
Current Pharmaceutical Design
|
May 28, 2016
Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile
Amir Abbas Momtazi, Amirhossein Sahebkar
Journal of Cellular and Molecular Medicine
|
October 31, 2021
Berberine as a promising natural compound for the treatment of periodontal disease: A focus on anti-inflammatory properties
Saeed Mohammadian Haftcheshmeh, Amir Abbas Momtazi-Borojeni
Cardiology Journal
|
January 8, 2025
Evaluating the effect of the antiPCSK9 vaccine on systemic inflammation and oxidative stress in an experimental mouse model
Amir Abbas Momtazi-Borojeni, Maciej Banach, Amirhossein Sahebkar
Phytotherapy Research : PTR
|
April 9, 2025
New Roles of Artemisinins in Atherosclerosis Progression
Hamidreza Majidiani, Maryam Musavi, Amir Abbas Momtazi-Borojeni
Pharmacological Research
|
January 3, 2017
Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity
Ramin Rezaee, Amir Abbas Momtazi, Alireza Monemi, et al.
Iranian Journal of Basic Medical Sciences
|
February 5, 2014
Antiproliferative activity and apoptosis induction of crude extract and fractions of avicennia marina
Amir Abbas Momtazi-Borojeni, Mandana Behbahani, Hojjat Sadeghi-Aliabadi
Journal of Cellular Physiology
|
January 7, 2017
Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades?
Elham Abdollahi, Amir Abbas Momtazi, Thomas P Johnston, et al.
Expert Review of Clinical Pharmacology
|
October 4, 2022
The role of PCSK9 in NAFLD/NASH and therapeutic implications of PCSK9 inhibition
Amir Abbas Momtazi-Borojeni, Maciej Banach, Massimiliano Ruscica, et al.
Current Medicinal Chemistry
|
October 29, 2021
PCSK9 Inhibition-Based Therapeutic Approaches: An Immunotherapy Perspective
Amir Abbas Momtazi-Borojeni, Matteo Pirro, Suowen Xu, et al.
Artificial Cells, Nanomedicine, and Biotechnology
|
October 14, 2017
Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma
Parvin Zamani, Maryam Matbou Riahi, Amir Abbas Momtazi-Borojeni, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 112) with videos related to
Sort By:
Page
of 12
Current Pharmaceutical Design
|
May 28, 2016
Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile
Amir Abbas Momtazi, Amirhossein Sahebkar
Journal of Cellular and Molecular Medicine
|
October 31, 2021
Berberine as a promising natural compound for the treatment of periodontal disease: A focus on anti-inflammatory properties
Saeed Mohammadian Haftcheshmeh, Amir Abbas Momtazi-Borojeni
Cardiology Journal
|
January 8, 2025
Evaluating the effect of the antiPCSK9 vaccine on systemic inflammation and oxidative stress in an experimental mouse model
Amir Abbas Momtazi-Borojeni, Maciej Banach, Amirhossein Sahebkar
Phytotherapy Research : PTR
|
April 9, 2025
New Roles of Artemisinins in Atherosclerosis Progression
Hamidreza Majidiani, Maryam Musavi, Amir Abbas Momtazi-Borojeni
Pharmacological Research
|
January 3, 2017
Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity
Ramin Rezaee, Amir Abbas Momtazi, Alireza Monemi, et al.
Iranian Journal of Basic Medical Sciences
|
February 5, 2014
Antiproliferative activity and apoptosis induction of crude extract and fractions of avicennia marina
Amir Abbas Momtazi-Borojeni, Mandana Behbahani, Hojjat Sadeghi-Aliabadi
Journal of Cellular Physiology
|
January 7, 2017
Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades?
Elham Abdollahi, Amir Abbas Momtazi, Thomas P Johnston, et al.
Expert Review of Clinical Pharmacology
|
October 4, 2022
The role of PCSK9 in NAFLD/NASH and therapeutic implications of PCSK9 inhibition
Amir Abbas Momtazi-Borojeni, Maciej Banach, Massimiliano Ruscica, et al.
Current Medicinal Chemistry
|
October 29, 2021
PCSK9 Inhibition-Based Therapeutic Approaches: An Immunotherapy Perspective
Amir Abbas Momtazi-Borojeni, Matteo Pirro, Suowen Xu, et al.
Artificial Cells, Nanomedicine, and Biotechnology
|
October 14, 2017
Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma
Parvin Zamani, Maryam Matbou Riahi, Amir Abbas Momtazi-Borojeni, et al.
Page
of 12